Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) was the target of unusually large options trading activity on Wednesday. Traders bought 3,845 call options on the company. This is an increase of 134% compared to the typical daily volume of 1,644 call options.
Quantum-Si Price Performance
QSI traded down $0.06 during trading on Friday, hitting $1.37. The company had a trading volume of 5,834,499 shares, compared to its average volume of 4,627,251. Quantum-Si has a 1-year low of $0.69 and a 1-year high of $3.10. The company has a market cap of $298.99 million, a PE ratio of -2.97 and a beta of 3.21. The business has a 50-day moving average of $0.79 and a 200-day moving average of $0.88.
Quantum-Si (NASDAQ:QSI – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The company had revenue of $0.34 million during the quarter, compared to analyst estimates of $0.30 million. Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. Research analysts forecast that Quantum-Si will post -0.47 earnings per share for the current year.
Analyst Ratings Changes
Read Our Latest Stock Report on Quantum-Si
Institutional Trading of Quantum-Si
Institutional investors and hedge funds have recently bought and sold shares of the company. Renaissance Technologies LLC bought a new stake in Quantum-Si during the first quarter valued at $91,000. WINTON GROUP Ltd bought a new position in shares of Quantum-Si in the 2nd quarter worth about $67,000. Green Alpha Advisors LLC acquired a new position in shares of Quantum-Si in the 2nd quarter valued at about $41,000. Corient Private Wealth LP acquired a new position in shares of Quantum-Si in the 2nd quarter valued at about $34,000. Finally, Hollencrest Capital Management grew its position in shares of Quantum-Si by 301.1% during the 1st quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after buying an additional 30,111 shares during the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.
Quantum-Si Company Profile
Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.
Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.
See Also
- Five stocks we like better than Quantum-Si
- Remitly’s September Pullback Tests a Still-Strong Growth Story
- Saddle Up: Texas Stock Exchange Ropes In $80 Billion in Listings
- Why Concentra’s Quiet Healthcare Business Keeps Winning
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
